Santhera Pharmaceuticals Holding AG (SPHDF)
OTCMKTS · Delayed Price · Currency is USD
16.28
0.00 (0.00%)
Feb 11, 2026, 4:00 PM EST

SPHDF Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
269185107816161
Market Cap Growth
28.12%72.13%31.69%33.01%0.46%-53.15%
Enterprise Value
299196155112100109
Last Close Price
16.289.4211.7014.1014.1031.40
PE Ratio
--1.65---
PS Ratio
4.364.280.8710.08-35.003.59
PB Ratio
-83.476.041.51-1.7242.04-8.49
P/FCF Ratio
--1.91---
P/OCF Ratio
--1.91---
EV/Sales Ratio
4.704.531.2613.82-6.41
EV/EBITDA Ratio
--2.42---
EV/EBIT Ratio
--2.54---
EV/FCF Ratio
-5.78-2.76---
Debt / Equity Ratio
-16.081.470.36-1.0232.36-11.20
Debt / EBITDA Ratio
--0.40---
Debt / FCF Ratio
--0.46---
Asset Turnover
0.410.301.190.10-0.15
Inventory Turnover
2.651.613.3713.408.292.84
Quick Ratio
0.511.190.710.050.710.58
Current Ratio
1.021.640.760.060.750.61
Return on Equity (ROE)
-288.14%-95.79%673.95%---908.60%
Return on Assets (ROA)
-26.60%-15.81%36.89%-36.95%-39.55%-32.56%
Return on Invested Capital (ROIC)
-250.98%-84.45%202.40%-406.92%-150.70%-103.78%
Return on Capital Employed (ROCE)
-69.70%-31.20%80.10%-319.80%-97.50%-89.00%
Earnings Yield
-30.64%-25.09%60.65%-94.37%-99.47%-125.46%
FCF Yield
-19.19%-21.32%52.24%-39.69%-66.92%-80.73%
Buyback Yield / Dilution
-9.97%-4.24%-79.29%-78.31%-156.61%-21.15%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.